Related Experiment Video
Updated: Jan 15, 2026

08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.6K
Improved Messenger RNA Stability and Biocompatibility Through Self-Gelatinizable Nucleic Acids
Takumi Tanifuji1, Kosuke Kusamori2, Chihiro Tanaka1
1Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Katsushika, Tokyo, Japan.
Biotechnology and Bioengineering
|January 14, 2026
Summary
Researchers developed a novel DNA hydrogel to stabilize messenger RNA (mRNA) therapeutics. This biocompatible platform enhances mRNA stability and reduces immunogenicity, offering a promising alternative to lipid nanoparticles for future therapies.
Area of Science:
- Biotechnology
- Materials Science
- Molecular Biology
Background:
- Messenger RNA (mRNA) therapeutics show promise but face challenges with in vivo instability and storage.
- Current lipid nanoparticle (LNP) delivery systems, while successful, can elicit immunogenic responses.
- Safer and more stable delivery platforms are needed for advanced mRNA therapies.
Purpose of the Study:
- To develop a novel, biocompatible delivery system for mRNA therapeutics.
- To address the limitations of mRNA instability and LNP immunogenicity.
- To evaluate the efficacy and safety of mRNA-loaded DNA hydrogels.
Main Methods:
- Designed DNA units were used to create self-assembling DNA hydrogels.
- Messenger RNA was loaded into the DNA hydrogel framework.
- In vitro assays were performed to assess protein expression, mRNA stability, and immunogenicity in relevant cell types (myofibroblasts and antigen-presenting cells).
Main Results:
- The DNA hydrogel demonstrated sustained mRNA-mediated protein expression in myofibroblasts.
- The hydrogel significantly enhanced resistance of mRNA to nuclease and storage degradation.
- Negligible proinflammatory cytokine production and cytotoxicity were observed in antigen-presenting cells.
Conclusions:
- mRNA-loaded DNA hydrogels represent a promising, biocompatible platform for next-generation mRNA therapeutics.
- This technology offers enhanced mRNA stability and reduced immunogenicity compared to existing methods.
- DNA hydrogels provide a viable alternative for developing safer and more effective mRNA-based treatments.
Related Concept Videos
RNA Stability
35.6K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.6K
mRNA Stability and Gene Expression
6.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
6.5K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K

